![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » BARR FILES FORMAL TENDER OFFER FOR PLIVA D.D. WITH HANFA
BARR FILES FORMAL TENDER OFFER FOR PLIVA D.D. WITH HANFA
July 28, 2006
Barr Pharmaceuticals, Inc. announced that its European subsidiary has officially filed a tender offer with the Croatian Financial Services Supervisory Agency (HANFA) to purchase 100% of the shares of PLIVA d.d., based in Zagreb, Croatia. In accordance with Croatian takeover law and HANFA instructions, Barr is prohibited from discussing the amount and specifics of its bid until HANFA
approval is received and Barr formally publishes the terms of its bid in Croatian
media.
PR
Newswire
KEYWORDS FDAnews Drug Daily Bulletin
Upcoming Events
-
21Oct